单位:[1]Beijing Key Lab Immune‑Mediated Inflammatory Diseases, Institute of Clinical Medical Science, China-Japan Friendship Hospital, Beijing, China[2]Department of Nephrology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China[3]Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China[4]Department of Endocrinology, China-Japan Friendship Hospital, Beijing, China
Background We aimed to examine the association of three mineral metabolism markers, including serum calcium, inorganic phosphorus, and intact parathyroid hormone with the risk of chronic kidney disease (CKD) at all stages. Methods This retrospective cohort study involved 3563 participants, including 3274 CKD patients and 289 healthy controls. CKD is diagnosed according to clinical guidelines from the 2012 KDIGO. Effect sizes are expressed odds ratio (OR) and 95 confidence interval (CI). Results After propensity score matching, per 0.5 mg/dL increment of inorganic phosphorus was significantly associated with 1.33-, 1.61-, and 2.85-fold increased risk of CKD at stages 1-2, 4, and 5, respectively. Regarding per 8 pg/mL increment of intact parathyroid hormone, significance was only noted for stage 5. In subsidiary analyses, the risk prediction of mineral metabolism markers under study was more evident in males and hypertensive subjects. A nomogram prediction model was constructed based on age, sex, and three mineral metabolism markers for CKD, with decent accuracy. Conclusions Our findings indicate that serum calcium was associated with all-stage CKD risk, whereas the association for inorganic phosphorus and intact parathyroid hormone was significant at advanced stages.
基金:
Key Projects in the National Science & Technology Pillar Program during Twelfth Five-Year Plan Period of China [2013BAI02B04]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81620108031]
第一作者单位:[1]Beijing Key Lab Immune‑Mediated Inflammatory Diseases, Institute of Clinical Medical Science, China-Japan Friendship Hospital, Beijing, China[2]Department of Nephrology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Jialin Li,Danni He,Wenjing Zhao,et al.Association of mineral metabolism biomarkers with chronic kidney disease in Chinese adults[J].CLINICAL and EXPERIMENTAL NEPHROLOGY.2021,25(7):760-770.doi:10.1007/s10157-021-02037-4.
APA:
Jialin Li,Danni He,Wenjing Zhao,Xi’ai Wu,Minjing Luo...&Ping Li.(2021).Association of mineral metabolism biomarkers with chronic kidney disease in Chinese adults.CLINICAL and EXPERIMENTAL NEPHROLOGY,25,(7)
MLA:
Jialin Li,et al."Association of mineral metabolism biomarkers with chronic kidney disease in Chinese adults".CLINICAL and EXPERIMENTAL NEPHROLOGY 25..7(2021):760-770